Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 4/20 | 0.72 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.72 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.72 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.72 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | HTR2C | P28335 | 2/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | HRH1 | P35367 | 1/20 | 0.72 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.72 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anisodamine SCHEMBL30317064 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL27981908 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL30679509 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL31098813 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL28725258 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL620576 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL30679510 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL16167837 | 0.84 | CHRM1 (0.76) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Atropine SCHEMBL8854381 | 0.84 | CHRM1 (1.00) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Atropine SCHEMBL41317 | 0.84 | CHRM1 (1.00) | CHRM1CHRM2CHRM5CHRM3CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616688-B2 | Cell glycocalyx protection effect of anisodamine | CHENGDU FIRST PHARMACEDTICAL CO., LTD (CN) | 2026-05-05 | — | — | US | claimed |
| CN-120118309-A | Preparation method of crosslinked conductive polymer/Graphene Oxide (GO) composite material, and product and application thereof | 上海纳米技术及应用国家工程研究中心有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-118007318-A | Solar-driven interface water evaporation and photocatalytic dye degradation dual-functional composite fiber membrane and preparation method and application thereof | 成都大学 | 2024-05-10 | — | — | CN | claimed |
| CN-117740902-A | Cuprous oxide-based ternary composite sensing electrode and preparation method and application thereof | 南京工业大学 | 2024-03-22 | — | — | CN | claimed |
| EP-4076733-B1 | PEROVSKITE SOLAR CELL PROVIDED WITH AN ADSORBENT MATERIAL FOR ADSORBING TOXIC MATERIALS | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2024-02-07 | — | — | EP | claimed |
| US-20230321072-A1 | CELL GLYCOCALYX PROTECTION EFFECT OF ANISODAMINE | CHENGDU FIRST PHARMACEDTICAL CO., LTD (CN) | 2023-10-12 | — | — | US | claimed |
| US-20230088203-A1 | PEROVSKITE SOLAR CELL PROVIDED WITH AN ADSORBENT MATERIAL FOR ADSORBING TOXIC MATERIALS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2023-03-23 | — | — | US | claimed |
| CN-115427142-A | Perovskite solar cell provided with adsorbing material for adsorbing toxic substances | 洛桑联邦理工学院(EPFL) | 2022-12-02 | — | — | CN | claimed |
| EP-4076733-A1 | PEROVSKITE SOLAR CELL PROVIDED WITH AN ADSORBENT MATERIAL FOR ADSORBING TOXIC MATERIALS | Ecole Polytechnique Fédérale de Lausanne (EPFL) EPFL-TTO (CH) | 2022-10-26 | — | — | EP | claimed |
| US-12616688-B2 | Cell glycocalyx protection effect of anisodamine | CHENGDU FIRST PHARMACEDTICAL CO., LTD (CN) | 2026-05-05 | — | — | US | disclosed |
| CN-121263029-A | Anti-solvent trans-perovskite battery based on carbon disulfide mixed anisole and preparation method thereof | 成都理工大学 | 2026-01-02 | — | — | CN | disclosed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | disclosed |
| CN-114875107-B | POLR2A as biomarker for treating tumor | 中南大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-120042065-A | Polyamide fiber with antibacterial and deodorizing functions and preparation method thereof | 福建省力恒锦纶实业有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-110776654-B | Aramid nanofiber/polyvinyl alcohol/polyaniline composite hydrogel and preparation method and application thereof | 南京理工大学 | 2022-06-28 | — | — | CN | disclosed |
| CN-111099588-B | Controllable preparation method of biomass gel-based hierarchical pore ordered three-dimensional network structure carbon material | 河南师范大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-110894343-B | MoO (MoO)3@ PEDOT composite material and preparation and application thereof | 中国科学院理化技术研究所 | 2022-06-21 | — | — | CN | disclosed |
| CN-114628166-A | Preparation method of asymmetric fibrous flexible supercapacitor | 闽都创新实验室 | 2022-06-14 | — | — | CN | disclosed |
| CN-114275767-A | Transition metal nitride/two-dimensional nitrogen-doped carbon composite material and preparation method thereof | 华中科技大学 | 2022-04-05 | — | — | CN | disclosed |
| CN-113968853-A | Hapten and artificial antigen of atropine alkaloid, and preparation method and application thereof | 中国农业大学 | 2022-01-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616688-B2 | Cell glycocalyx protection effect of anisodamine | CD14, ICAM1, VCAM1 | CHRM1 1006/4885CHRM2 2061/4885CHRM5 1919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.